An elevated serum level of CRP (>1.0 mg/dl) is associated with both an increased risk in all cancer [19] and a prognostic factor for survival and recurrence in different types of both carcinoma, including breast, prostate, colon, and hepatocellular carcinoma, and also bone and soft-tissue sarcoma [20–23] including osteosarcoma, Ewing’s sarcoma and chondrosarcoma. This evidence concerns the gene CRP and cancer.